Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Biological Products × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Refractory/Relapse Neuroblastoma 1 Papillomavirus Infections 1 Osteoporosis 1 Neuroendocrine Tumors 1 Neoplasms, Squamous Cell 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, B-Cell 1 Kidney Neoplasms 1 Inflammatory Bowel Diseases 1 Infertility 1 Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1 Hodgkin Disease 1 High Grade Cervical Intraepithelial Neoplasia 1 Esophageal Neoplasms 1 Burkitt Lymphoma 1

Interventions

Oxaliplatin 46 Gemcitabine 45 Fluorouracil 40 Capecitabine 31 pembrolizumab 30 Leucovorin 29 Docetaxel 27 Cisplatin 25 Paclitaxel 23 Irinotecan 18 Carboplatin 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 17 Radiotherapy 16 Pemetrexed 15 Albumin-Bound Paclitaxel 15 Nivolumab 13 Ramucirumab 11 Cyclophosphamide 11 Drug Therapy 9 Trastuzumab 8 Erlotinib Hydrochloride 8 zolbetuximab 7 Taxes 7 Radiosurgery 7 trastuzumab deruxtecan 6 cemiplimab 6 Blood Specimen Collection 6 regorafenib 5 durvalumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01413087 2019-11-01

LAPC-BC-819

Anchiano Therapeutics Israel Ltd.

Phase 2 Terminated

12 enrolled 19 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡